WallStreetZenWallStreetZen

NYSE: PBH
Prestige Consumer Healthcare Inc Earnings & Revenue

Open Broker Account

PBH past earnings growth

How has PBH's earnings growth performed historically?
Company
13.48%
Industry
2.93%
Market
51.52%
PBH's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PBH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
PBH's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

PBH past revenue growth

How has PBH's revenue growth performed historically?
Company
11.34%
Industry
10.99%
Market
121.28%
PBH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PBH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PBH's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PBH earnings and revenue history

Current Revenue
$1.1B
Current Earnings
$202.9M
Current Profit Margin
18.5%
PBH's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

PBH Return on Equity

Current Company
13.2%
Current Industry
74.6%
Current Market
25.7%
PBH's Return on Equity (13.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PBH announces earnings.

PBH Return on Assets

Current Company
5.5%
Current Industry
2.7%
PBH is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PBH Return on Capital Employed

Current Company
9.12%
Current Industry
13.4%
PBH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PBH vs Medical Distribution Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PBH$1.09B$360.88M$202.90M+3.34%+14.42%
PDCO$6.41B$356.73M$193.80M+2.86%+2.96%
OMI$9.88B$400.28M$153.99M+1.04%+6.02%
HSIC$12.72B$1.10B$650.52M+1.22%+15.10%
CAH$181.36B$71.00M-$933.00M+6.89%N/A

PBH earnings dates

Next earnings date
Nov 2, 2022

Prestige Consumer Healthcare Earnings & Revenue FAQ

What were PBH's earnings last quarter?

On Invalid Date, Prestige Consumer Healthcare (NYSE: PBH) reported Q2 2022 earnings per share (EPS) of $1.10, up 4.35% year over year. Total Prestige Consumer Healthcare earnings for the quarter were $55.27 million. In the same quarter last year, Prestige Consumer Healthcare's earnings per share (EPS) was $1.15.

If you're new to stock investing, here's how to buy Prestige Consumer Healthcare stock.

What was PBH's earnings growth in the past year?

As of Q3 2022, Prestige Consumer Healthcare's earnings has grown 13.48% year over year. This is 10.56 percentage points higher than the US Medical Distribution industry earnings growth rate of 2.93%. Prestige Consumer Healthcare's earnings in the past year totalled $202.90 million.

What is PBH's earnings date?

Prestige Consumer Healthcare's earnings date is Invalid Date. Add PBH to your watchlist to be reminded of PBH's next earnings announcement.

What was PBH's revenue last quarter?

On Invalid Date, Prestige Consumer Healthcare (NYSE: PBH) reported Q2 2022 revenue of $277.06 million up 2.93% year over year. In the same quarter last year, Prestige Consumer Healthcare's revenue was $269.18 million.

What was PBH's revenue growth in the past year?

As of Q3 2022, Prestige Consumer Healthcare's revenue has grown 11.34% year over year. This is 0.35 percentage points higher than the US Medical Distribution industry revenue growth rate of 10.99%. Prestige Consumer Healthcare's revenue in the past year totalled $1.09 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.